Newsroom
Newsroom
Press Release
December 11, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has completed the previously announced acquisition of Nucleus Global, creating a global leader in Medical Communications. The terms of the transaction were not disclosed.
The combination...
Press Release
December 9, 2020
CD&R is pleased to support the newly launched Diversity in Action initiative of the Institutional Limited Partners Association (ILPA) as a founding signatory.
The initiative aligns with CD&R’s commitment to advance diversity, equity, and...
Press Release
November 6, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has announced an agreement to acquire Nucleus Global from its founder, Stephen Cameron.
The combination will create a global leader in the fast growing medical communications space and...
Press Release
November 6, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has announced an agreement to acquire Nucleus Global from its founder, Stephen Cameron.
The combination will create a global leader in the fast growing medical communications space and...
Media Coverage
October 27, 2020
Private equity can offer more than just capital--this firm has a long history of making operational improvements.
Media Coverage
October 27, 2020
Inc. Magazine published its second annual list of private equity firms known for being good partners to entrepreneurs. CD&R is proud to be recognized for its work with family and founder-led companies and included on the list.
Press Release
October 14, 2020
Clayton, Dubilier & Rice today announced the closing of CD&R funds’ acquisition of Epicor, a global provider of industry-specific enterprise software to industrial sectors. The transaction is valued at $4.7 billion.
Epicor is a leading...
Events
September 24, 2020
CD&R’s Operating Partner Vindi Banga served as a discussion leader at the World Economic Forum’s Sustainable Development Impact Summit, where he outlined the long-term value creation case for engagement on environmental, social and governance (...
Press Release
August 31, 2020
Clayton, Dubilier & Rice, KKR, and Epicor Software Corporation today announced a definitive agreement whereby CD&R funds will acquire Epicor, a global provider of industry-specific enterprise software to industrial-focused sectors, from...
Press Release
August 11, 2020
Clayton, Dubilier & Rice today announced an agreement with HD Supply Holdings, Inc. (NASDAQ:HDS) under which CD&R funds will lead an investment to acquire HD Supply’s Construction & Industrial business (also known as “White Cap”), a...
- ‹ previous
- 14 of 31
- next ›
The latest insights from
September 15, 2020
Working Capital Review
As early as 2014, global CEOs were already seeing sustainability as a core part of their business... Read More
September 9, 2020
Chris Riback
Joe Coughlin, CEO & Founder of Corporate Risk Solutions
Businesses, of course, face risk every... Read More
June 30, 2020
Working Capital Review
Back in April, we discussed ‘Downsizing the Workforce? It’s a Mistake to Skimp on Cyber Security’ ... Read More
June 2, 2020
Working Capital Review
The risks associated with COVID-19 are more than just to our health. The world economy sustained a... Read More
The latest podcasts from
April 10, 2022
Chris Riback
Working Capital Conversations offers engaging podcasts on business, technology and innovation.Visit... Read More
March 6, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture.The bi-weekly show... Read More
February 13, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture. The bi-weekly show... Read More
February 6, 2022
Chris Riback
We know the headlines: Inflation is the highest in 40 years, climbing 7 percent last year.... Read More
Press Release
March 6, 2015
Clayton, Dubilier & Rice (“CD&R”) today announced that Ravi Sachdev, former Managing Director for Healthcare Coverage and Co-Head of Healthcare Services at J.P. Morgan, will join the Firm as a Partner.
Mr. Sachdev brings to CD&R...
Media Coverage
November 2, 2014
As part of its annual Awards for Operational Excellence, Private Equity International recognized CD&R’s Rexel investment in October 2014. Under CD&R’s ownership, Rexel built market leadership positions in developed and emerging markets...
Press Release
August 24, 2014
Clayton, Dubilier & Rice (“CD&R”) and MAUSER Group (“MAUSER”) announced today that funds managed by CD&R have completed the previously-announced acquisition of MAUSER, one of the world;s leading industrial packaging companies. The...
Press Release
August 21, 2014
CHC Group Ltd. (NYSE: HELI) and Clayton, Dubilier & Rice (CD&R) today announced they have entered into definitive agreements for CD&R managed funds to invest $500 million in CHC through the purchase of convertible preferred shares to be...
Press Release
August 1, 2014
Ashland Water Technologies has a new name - Solenis. Rooted in “solutions” and “genesis,” the name underscores the company’s mission to be at the source - the genesis - of solutions for its customers.
The name change coincides with the acquisition...
Press Release
July 1, 2014
Clayton, Dubilier & Rice (“CD&R”) and Healogics Holding Corp. (“Healogics”) announced today that funds managed by CD&R have completed the previously-announced acquisition of Healogics, the largest advanced wound care services provider in...
Press Release
May 9, 2014
As an extraordinarily effective and inspirational executive, B. Charles “Chuck” Ames has used his leadership position and vast knowledge to help educate and assist the next generation of management leaders as a mentor, collaborator, author and...
Press Release
February 18, 2014
Clayton, Dubilier & Rice (“CD&R”) and Ashland Inc. (NYSE:ASH) today announced an agreement under which a CD&R-managed fund will acquire Ashland Water Technologies (“AWT”), a leading global supplier of specialty chemicals for process,...
Press Release
January 29, 2014
Clayton, Dubilier & Rice (“CD&R”) today announced the close of an investment in PharMEDium Healthcare Corporation (“PharMEDium” or the “Company”), the leading national provider of hospital pharmacy-outsourced sterile compounding services....
Press Release
December 19, 2013
PharMEDium, the leading national provider of hospital pharmacy-outsourced sterile compounding services, today announced an agreement under which a fund managed by Clayton, Dubilier & Rice (CD&R) will invest in the company. Oak Investment...
- ‹ previous
- 25 of 31
- next ›
The latest insights from
September 15, 2020
Working Capital Review
As early as 2014, global CEOs were already seeing sustainability as a core part of their business... Read More
September 9, 2020
Chris Riback
Joe Coughlin, CEO & Founder of Corporate Risk Solutions
Businesses, of course, face risk every... Read More
June 30, 2020
Working Capital Review
Back in April, we discussed ‘Downsizing the Workforce? It’s a Mistake to Skimp on Cyber Security’ ... Read More
June 2, 2020
Working Capital Review
The risks associated with COVID-19 are more than just to our health. The world economy sustained a... Read More
The latest podcasts from
April 10, 2022
Chris Riback
Working Capital Conversations offers engaging podcasts on business, technology and innovation.Visit... Read More
March 6, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture.The bi-weekly show... Read More
February 13, 2022
Chris Riback
The Call In podcast helps leaders navigate today’s cancel culture. The bi-weekly show... Read More
February 6, 2022
Chris Riback
We know the headlines: Inflation is the highest in 40 years, climbing 7 percent last year.... Read More
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.